 Connection
Peter Kabos to Receptor, Fibroblast Growth Factor, Type 1
This is a "connection" page, showing publications Peter Kabos has written about Receptor, Fibroblast Growth Factor, Type 1.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.369 |
|
|
|
-
Fox MS, Jaramillo-Gómez JA, Marquez-Ortiz RA, Alvarez-Eraso KLF, Contreras-Zárate MJ, Pham TC, Barela EN, Koliavas SN, Kabos P, Serkova NJ, Sartorius CA, Wellberg EA, Cittelly DM. Brain FGF2 and NCAM1 contribute to FGFR1-dependent progression of estrogen receptor-positive breast cancer brain metastases. Nat Commun. 2026 May 28; 17(1).
Score: 0.233
-
Wellberg EA, Kabos P, Gillen AE, Jacobsen BM, Brechbuhl HM, Johnson SJ, Rudolph MC, Edgerton SM, Thor AD, Anderson SM, Elias A, Zhou XK, Iyengar NM, Morrow M, Falcone DJ, El-Hely O, Dannenberg AJ, Sartorius CA, MacLean PS. FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivation. JCI Insight. 2018 07 26; 3(14).
Score: 0.136
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|